Streetbeat News

Stock Prices

AMZN

GOOG

MSFT

ONLN

XLY

Amazon AWS introduced Deadline Cloud, a service for the media and entertainment industry to facilitate rendering pipelines using AWS cloud. This service aims to meet the growing demand for high-quality rendering and generative AI content. AWS competes with Microsoft and Alphabet's Google in the cloud computing market. AWS's expansion includes a $10B investment in Mississippi and plans for data center expansions in Mexico and Japan. AMZN stock is slightly down in premarket trading, while exposure to AMZN can also be gained through XLY and ONLN ETFs.

Portfolio Pulse from Anusuya Lahiri

April 03, 2024 | 11:45 am

OUST

Ouster shares are trading lower following a downgrade by Chardan Capital from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:43 am

CASA

Casa Systems' shares are trading lower following the company's filing for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:42 am

LOW

Lowe's Companies, Inc. (LOW) shares are trading lower following a downgrade by Gordon Haskett from Accumulate to Hold.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:41 am

FIVE

Five Below's stock trades lower following a downgrade by Gordon Haskett from Buy to Accumulate and a reduction in price target from $210 to $200.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:39 am

KTRA

Kintara Therapeutics has entered into a merger agreement with TuHURA Biosciences, causing its shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:36 am

HSDT

Helius Medical Technologies' stock is trading higher following the announcement of a partnership with Lovell Government Services to distribute its PoNS device to federal healthcare systems.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:36 am

ORGO

Organogenesis Holdings Inc. announced that the United States District Court has dismissed a securities fraud case against the company. This legal victory is significant for Organogenesis, as it removes a major legal hurdle and potential financial liability.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:33 am

FIVE

Gordon Haskett analyst Chuck Grom downgrades Five Below (NASDAQ:FIVE) from Buy to Accumulate and lowers the price target from $210 to $200.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:32 am

FEAM

5E Advanced Materials has started commercial production at its 5E Boron Americas Complex, leading to an increase in its share price.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 11:30 am